차바이오텍

085660KOSDAQView the 제약 sectorTheme Bio & healthcare

7,570KRWMarket close of 10/21 (Wed)

Down -1.17%-90KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)7,370KRWDown -2.64%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
7,810
High
7,950
Low
7,550
Day range
Day range low 7,550 high 7,950, open 7,810, close 7,570, previous close 7,660
Volume
13×10K shares
992.65 million KRW 0.63× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 7,370 to 23,850 won, 1% up from the low

1% of the way up from the lowest close in 1 year (252 sessions) · -68.3% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-74.4B KRWOperating income over the last four quarters -74.4B KRW (loss)Operating income, 8 quarters
  • Daily moveusual range-1.17%-1.17%, 0.5× the usual (20-session average ±2.36%)
    That day -1.17% · usual ±2.36% · large-move threshold ±4.7%
  • Trading valueusual range0.6×992.65 million KRW, 0.6× the 20-session average
    0.63× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+700.00 million KRWusual range
  • Data date10/21 (Wed)Market close
See the full check report

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
셀트리온Close over the last 20 sessions +9.6%Up +0.10%119.2B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 25 days
  • Next data 10/23 (Fri) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.